Search details
1.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cancer
; 126(23): 5069-5076, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32910456
2.
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Hematol Oncol
; 38(5): 754-762, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32950042
3.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Hemasphere
; 7(4): e837, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37034003
4.
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
Haematologica
; 100(12): e501-4, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26294723
5.
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.
Leuk Lymphoma
; 60(12): 3044-3050, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31120311
6.
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma.
Hematol Oncol
; 29(3): 151-3, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-20872912
7.
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Leuk Lymphoma
; 56(4): 921-6, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25110825
Results
1 -
7
de 7
1
Next >
>>